Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of British Columbia

$17,500.00

Investigating the relationship between epigenetic regulators and molecular characteristics at single cell resolution in breast and ovarian cancer genomes.

FY 2022-23

Summary
Advanced breast cancer and ovarian cancer are deadly diseases with limited treatment options, in part due to the variability between and within patients on the genetic level. This variability is masked by bulk tissue analysis which makes it difficult to observe subgroups of cells within a tumour that share a common genetic change, referred to as clones. Fitness describes the competition between clones for survival in a cancer and provides a basis for cancer evolution, such as different susceptibility to drug therapies. New methods to study the single cells of clones in animal models representing the inherent variability of individual patients will identify candidate genes and their interactions that contribute to the complex multicellular behaviours of breast and ovarian cancer tumours. This is key to understanding who might respond to chemotherapy and crucial for the development of emerging genetically targeted therapies. I propose to combine existing experimental and statistical methods for assessing gene fitness at single cell resolution and apply this method to patient-derived mice models of different patient tumours treated with chemotherapy or novel DNA targeting drugs. This project will focus on epigenetics, various marks on DNA and proteins that alter gene expression, and their role in breast and ovarian cancer progression. Individual tumour cells will be sequenced after knocking out different genes that regulate epigenetics to identify the most important genes and how they impact tumour growth. This work will contribute to our understanding of the role of epigenetic regulators in cancer and its evolution over time, as well as their impact on the response to current and emerging therapeutic options in patients with breast or ovarian cancer.
Program
Master's Award: Canada Graduate Scholarships
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
486029
Name
Liu Yi Fei
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating the relationship between epigenetic regulators and molecular characteristics at single cell resolution in breast and ovarian cancer genomes.
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Breast Cancer; Clonal Dynamics; Drug Resistance; Epigenetics; Genomic Instability; Ovarian Cancer; Patient-Derived Xenograft; Pooled Crispr Screen; Single Cell Transcriptomics; Tumour Heterogeneity
Abstract
Advanced breast cancer and ovarian cancer are deadly diseases with limited treatment options, in part due to the variability between and within patients on the genetic level. This variability is masked by bulk tissue analysis which makes it difficult to observe subgroups of cells within a tumour that share a common genetic change, referred to as clones. Fitness describes the competition between clones for survival in a cancer and provides a basis for cancer evolution, such as different susceptibility to drug therapies. New methods to study the single cells of clones in animal models representing the inherent variability of individual patients will identify candidate genes and their interactions that contribute to the complex multicellular behaviours of breast and ovarian cancer tumours. This is key to understanding who might respond to chemotherapy and crucial for the development of emerging genetically targeted therapies. I propose to combine existing experimental and statistical methods for assessing gene fitness at single cell resolution and apply this method to patient-derived mice models of different patient tumours treated with chemotherapy or novel DNA targeting drugs. This project will focus on epigenetics, various marks on DNA and proteins that alter gene expression, and their role in breast and ovarian cancer progression. Individual tumour cells will be sequenced after knocking out different genes that regulate epigenetics to identify the most important genes and how they impact tumour growth. This work will contribute to our understanding of the role of epigenetic regulators in cancer and its evolution over time, as well as their impact on the response to current and emerging therapeutic options in patients with breast or ovarian cancer.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Liu, Yi Fei
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~